ATMI And Disposable-Lab Introduce First Single-Use Platform For Fill/Finish Operations

DANBURY, Conn., April 12, 2013 (GLOBE NEWSWIRE) -- ATMI, Inc. (Nasdaq:ATMI), a global technology company and a leader in single-use process solutions, today introduced the first all-single-use fill/finish platform for pharmaceutical and biopharmaceutical applications that is compliant with current good manufacturing practices (cGMP). The platform is designed for bioprocess applications from clinical batch to industrial scale, with fills ranging from 0.2 milliliters to 100 Liters. This unique solution is offered by ATMI LifeSciences through an exclusive agreement with France-based Disposable-Lab, S.A.S., a clinical filling services and contract manufacturing organization (CMO). ATMI and Disposable-Lab will jointly commercialize the technology. The fill/finish platform will be on display at the upcoming INTERPHEX trade show in New York, NY, April 23 rd – 25 th at booth #3319.

The disposable platform is modeled after traditional manufacturing fill/finish processes, but on a much smaller scale. All of the process equipment used in conjunction with the fill/finish platform is disposable, including the connectors, vials, baskets and caps, to form a completely disposable process equipment platform. As such, the platform minimizes maintenance costs and provides a smaller footprint versus traditional systems. The easier to use format also delivers time savings during setup and operation.

"This is the only platform of its kind on the market, and it is an excellent fit for our single-use product portfolio," noted Senior Vice President and General Manager of ATMI LifeSciences Mario Philips. "As innovators ourselves, we saw a great deal of potential in Disposable-Lab's technology. Customers will benefit from having access to the disposable fill/finish platform, as well as from our collaboration. When combined with the mixing system, bioreactor and vessel offers we already have in place, this new addition allows us to provide customers with a truly comprehensive range of single-use technology solutions."

Operation of the platform involves decontaminating the non-disposable box in/flushing isolator with hydrogen peroxide. The vial baskets are then manually placed in the preparation isolator before the vials are filled using disposable dispensing needles in the transfer area. Weighing and capping operations are performed in a sterile finishing isolator, where the vials are closed in one step prior to weighing.

If you liked this article you might like

Why Entegris (ENTG) Stock Is Higher Today

ATMI Inc. Stock Downgraded (ATMI)

Entegris Acquires ATMI For $1B

Entegris (ENTG) Buys ATMI (ATMI) For $1.15 Billion

ATMI Inc. Stock Upgraded (ATMI)